Search results for: “Indian Pharma Sector”
-
Rubicon Research IPO: A Game-Changer for Indian Pharmaceutical Sector?
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what Indian investors need to know.
-
Samvat 2082: Indian Stock Market Poised for Growth – A Review of Sectoral Winners and Losers
The Indian stock market is poised to maintain its momentum in Samvat 2082, with the Nifty 50 index delivering a moderate return of 6% and the Nifty Bank posting a strong gain of 12% in the last year.
-
Indian Stock Market News: Nifty Above 25,800, Sensex Rises Nearly 400 Points
Latest updates from the Indian stock markets including Nifty levels, Q2 results, and major corporate actions affecting investor sentiment.
-
US Stock Market Today: Impact of China-US Trade War on Indian Investors
The ongoing China-US trade war has sent shockwaves through global markets, with the Dow Jones and S&P 500 experiencing significant volatility. What does this mean for Indian investors?
-
Prasol Chemicals Files for Rs 500 Crore IPO: What Indian Investors Need to Know
Prasol Chemicals Ltd. has filed for an initial public offering worth Rs 500 crore. Here’s what Indian investors should know about the company and its IPO plans.
-
How the U.S. Shelved Tariffs on Generic Drugs — A Lifeline for India’s Pharma
White House shelves tariffs on generic drugs, easing pressure on U.S. patients and Indian pharma exports—insight into impact, risks, and strategy. Imagine walking into a pharmacy tomorrow, only to find your essential medications have suddenly skyrocketed in price. For millions of Americans and healthcare systems worldwide, the threat of tariffs on pharmaceutical imports is more…
-
Fabtech Technologies IPO Listing: A Muted Debut for the Biopharma Engineering Company
Fabtech Technologies Ltd. made a muted debut on the stock market, listing nearly the same to the IPO price. Get the latest updates on the company’s performance and its implications for Indian investors.
-
Rubicon Research IPO: A Game-Changer for Indian Pharmaceutical Industry
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what you need to know about this highly anticipated IPO.
-
Navratri Stock Market D-Street: Understanding the Slump in Indian Equity Markets
The Indian equity markets have consistently ended the Navratri festival week in the red since 2022, reversing the trend of strong festive cheer. What are the factors contributing to this slump and what can investors expect in the future?
-
“Trump’s 100% Pharma Tariff: What It Means for Indian Pharma Drugmakers”
Explore the implications of President Trump’s 100% tariff on branded drugs for Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s. In a bold move that has sent ripples through the global pharmaceutical industry, President Donald Trump announced a 100% tariff on imported branded and patented drugs, effective October 1, 2025. This decision has…
-
How to Use “Stocks at 52 Week High by Sector” to Find Winning Sectors
Have you ever looked at the stock market and wondered which sectors are genuinely hot right now? It’s one thing for an individual share to be surging — but when many stocks in a particular sector are hitting their 52-week highs, that’s a signal of broad strength. Tracking the number of stocks at 52-week high…
-
Why India Stock Market Rose Today: Fed Moves, Sector Picks & Where Nifty Heads Next
Have you ever felt that moment when global finance shifts—just a little—and suddenly markets across the world seem to catch their breath overnight? That’s where India stands today. A modest decision by the U.S. Federal Reserve rippled all the way to Dalal Street, lifting optimism, spurring speculation—and pulling India’s benchmark indices into the green. In…
-
Indian Stock Market News: Sensex Gains, Green Bond Milestone & Sector Trends (Sept 19)
Indian stock market news September 19, 2025: KPI Green’s first green bond, SEPC’s water project, Biocon’s FDA win & buzzing stocks today. Every morning, traders and investors wake up asking the same question: “What’s moving the market today?” The Indian stock market isn’t just numbers on a screen—it’s a story of global cues, local policy…
-
“When Trump’s Tariffs Sting: A Human Guide for Indian Investors Thinking ‘Buy the Dip”
“Explore how Indian investors can navigate U.S.‑India tariff turmoil and apply a smart ‘buy the dip’ strategy—learn when to act, hold, diversify, and thrive.” Ever felt like your investments are stranded in a waiting room, watching headlines about U.S. tariffs, rupee moves, and export meltdowns? You’re not alone—and there is a way forward. This blog…
-
How the Indian Stock Market Pulled Off Marginal Gains Despite Trump’s 50% Tariff Shock
Markets hold on despite Trump’s tariff threat—deep-dive into sectors, psychology, and strategy. Primary Keyword: “Indian stock market marginal gains” Have you ever watched your investments bounce back in the last minute, leaving you half‑confused, half‑relieved? That’s exactly what happened in the Indian markets on Thursday, August 7, 2025. The Sensex eked out a 79‑point gain…